RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: multiple sclerosis
Accession: DOID:2377
browse the term
Definition: A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring. (DO)
Synonyms: exact_synonym: MS; MS (Multiple Sclerosis); acute fulminating multiple sclerosis; disseminated sclerosis; generalized multiple sclerosis; insular sclerosis
related_synonym: MS1; MS2; MS3; MS4; MS5; multiple sclerosis modifier of disease progression; multiple sclerosis, susceptibility to; multiple sclerosis, susceptibility to, 1; multiple sclerosis, susceptibility to, 2; multiple sclerosis, susceptibility to, 3; multiple sclerosis, susceptibility to, 4; multiple sclerosis, susceptibility to, 5
primary_id: MESH:D009103
alt_id: OMIM:126200 ; OMIM:612594 ; OMIM:612595 ; OMIM:612596 ; OMIM:614810
xref: EFO:0003885 ; GARD:10255 ; ICD10CM:G35 ; ICD9CM:340 ; MONDO:0005301 ; NCI:C3243 ; OMIM:PS126200
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for the selected species.
G
ACAN
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr29:7,345,350...7,416,951
G
ACHE
acetylcholinesterase (Cartwright blood group)
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr28:12,328,304...12,335,302
Ensembl chr28:12,331,039...12,335,076
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
G
AGT
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
G
AIM2
absent in melanoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:4,759,746...4,884,460
Ensembl chr20:4,873,008...4,884,764
G
APOA1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
APOC2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr 6:38,406,829...38,411,239
Ensembl chr 6:38,409,641...38,410,927
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
B4GALT5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr 2:14,270,945...14,357,052
Ensembl chr 2:14,271,141...14,354,159
G
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:49,037,348...49,101,769
Ensembl chr18:49,037,225...49,102,502
G
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
G
BDNF
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr12:75,441...335,980
Ensembl chr12:78,011...335,820
G
CASP1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 1:96,389,697...96,400,610
Ensembl chr 1:96,389,657...96,400,849
G
CAV1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr21:85,222,724...85,258,562
Ensembl chr21:85,222,879...85,258,627
G
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr22:74,961,831...75,181,307
Ensembl chr22:74,961,859...75,178,548
G
CCL1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr16:27,868,925...27,890,143
G
CCL13
C-C motif chemokine ligand 13
ISO
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr16:27,864,260...27,867,457
Ensembl chr16:27,865,318...27,867,415
G
CCL2
C-C motif chemokine ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr16:29,351,214...29,361,317
G
CCL7
C-C motif chemokine ligand 7
ISO
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 RGD:6483818
NCBI chr16:27,777,795...27,780,413
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr22:7,648,410...7,698,523
Ensembl chr22:7,697,068...7,698,135
G
CCR5
C-C motif chemokine receptor 5
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr22:7,803,794...7,818,112
G
CD24
CD24 molecule
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr13:66,863,164...66,868,951
G
CD28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr10:89,471,710...89,505,152
Ensembl chr10:89,471,730...89,500,387
G
CD40
CD40 molecule
susceptibility
ISO
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
G
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:30,039,854...30,132,646
Ensembl chr 1:30,039,749...30,132,416
G
CD46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr25:21,650,825...21,693,898
Ensembl chr25:21,655,969...21,693,878
G
CD58
CD58 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr20:17,152,663...17,208,646
Ensembl chr20:17,152,777...17,208,671
G
CD6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr 1:12,827,238...12,878,304
Ensembl chr 1:12,828,285...12,877,704
G
CD86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
G
CD96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr22:69,141,470...69,245,962
Ensembl chr22:69,140,288...69,244,097
G
CDK17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:91,641,917...91,757,925
Ensembl chr11:91,640,374...91,757,876
G
CFH
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chr25:32,557,697...32,744,763
G
CIITA
class II major histocompatibility complex transactivator
no_association susceptibility
ISO
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:rs3087456, no association in a German cohort DNA:polymorphism:promoter:-168A>G
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chr 5:10,341,690...10,401,988
Ensembl chr 5:10,372,344...10,400,451
G
CLDN11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr15:18,991,734...19,006,902
Ensembl chr15:18,991,042...19,006,866
G
CLEC16A
C-type lectin domain containing 16A
ISO
DNA:polymorphism:intron:g.194570G>A, rs7184083 CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr 5:10,420,866...10,658,370
Ensembl chr 5:10,420,931...10,658,507
G
CMPK2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr14:100,804,295...100,820,565
Ensembl chr14:100,804,400...100,819,027
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chr16:64,288,583...64,296,940
Ensembl chr16:64,289,828...64,296,922
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr13:12,626,259...12,653,253
Ensembl chr13:12,630,270...12,631,688
G
CNTF
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr 1:14,724,562...14,730,698
Ensembl chr 1:14,728,383...14,730,150
G
COL1A1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr16:43,134,648...43,152,313
Ensembl chr16:43,134,779...43,150,930
G
CST3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:12589965 PMID:17086443
RGD:5686392 RGD:5686394
NCBI chr 2:52,834,497...52,838,785
Ensembl chr 2:52,832,181...52,838,865
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chr10:89,637,176...89,644,436
Ensembl chr10:89,638,314...89,642,344
G
CTSB
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chr 8:7,246,076...7,269,655
Ensembl chr 8:7,246,013...7,268,854
G
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr26:4,451,731...4,473,220
Ensembl chr26:4,451,774...4,472,855
G
CTSL
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr12:98,347,770...98,353,426
Ensembl chr12:98,347,800...98,353,467
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868
NCBI chr11:53,675,704...53,681,372
Ensembl chr11:53,675,226...53,680,443
G
DNAAF11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 8:127,010,303...127,103,343
Ensembl chr 8:127,008,619...127,103,300
G
DUSP28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:126,587,748...126,592,419
Ensembl chr10:126,588,867...126,589,861
G
EDN1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr16:57,145,080...57,233,757
Ensembl chr16:57,145,191...57,236,230
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism DNA:repeat:promoter:g.-46(CA)11-15 (human)
CTD RGD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
G
FCGR2A
Fc fragment of IgG receptor IIa
no_association
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chr20:2,480,710...2,512,429
G
FCGR3A
Fc fragment of IgG receptor IIIa
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr20:2,466,492...2,475,579
G
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:126,735,146...126,999,990
Ensembl chr X:126,735,288...127,000,017
G
GC
GC vitamin D binding protein
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human) protein:decreased expression:cerebrospinal fluid
CTD RGD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
G
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr11:53,371,929...53,384,339
Ensembl chr11:53,375,558...53,385,269
G
GRM8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr21:95,264,905...96,060,822
Ensembl chr21:95,264,765...96,050,554
G
GRN
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr16:62,037,344...62,045,765
Ensembl chr16:62,036,412...62,045,614
G
GSTM3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr20:23,797,794...23,802,910
Ensembl chr20:23,799,177...23,802,921
G
GSTP1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr 1:6,676,897...6,679,936
G
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr20:122,502,084...122,531,214
Ensembl chr20:122,503,687...122,526,074
G
HDAC1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr20:100,529,782...100,575,953
Ensembl chr20:100,530,369...100,558,556
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr17:27,914,261...27,921,666
Ensembl chr17:27,911,013...27,921,251
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IFNG
interferon gamma
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:repeat:intron: (human)
CTD RGD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
IGF2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL12A
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr15:30,887,048...30,896,577
Ensembl chr15:30,887,897...30,894,550
G
IL13
interleukin 13
severity
ISO
protein:increased expression:cerebrospinal fluid protein:increased expression:serum
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
G
IL17A
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
G
IL1B
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
G
IL21R
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chr 5:25,105,947...25,153,914
Ensembl chr 5:25,106,519...25,153,703
G
IL23R
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs2201841,rs10889677,s7517847(human) DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chr20:65,853,379...65,946,000
Ensembl chr20:65,854,349...65,938,024
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chr 9:6,134,961...6,187,731
Ensembl chr 9:6,141,430...6,149,447
G
IL4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
G
IL4R
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
G
IL6
interleukin 6
treatment severity
ISO
DNA:polymorphism:promoter:-174G>C(human) DNA:polymorphism:promoter:-572 G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 8:74,230,493...74,292,985
Ensembl chr 8:74,231,809...74,292,384
G
IL7R
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 4:34,701,724...34,724,241
Ensembl chr 4:34,701,531...34,721,361
G
IRF5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chr21:97,536,803...97,549,576
Ensembl chr21:97,537,790...97,549,945
G
IRF8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr 5:71,301,878...71,325,622
Ensembl chr 5:71,302,233...71,325,613
G
JAG1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chr 2:27,484,699...27,521,108
Ensembl chr 2:27,484,760...27,522,504
G
JARID2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:56,651,752...56,928,650
Ensembl chr17:56,651,596...56,928,126
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr20:3,873,915...3,907,587
Ensembl chr20:3,902,513...3,903,652
G
KIF1B
kinesin family member 1B
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chr20:121,393,478...121,567,704
Ensembl chr20:121,395,836...121,546,803
G
KIF5A
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr11:53,458,795...53,493,801
G
KLHL6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:5,844,728...5,912,392
Ensembl chr15:5,845,721...5,913,734
G
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr 6:43,980,680...43,991,873
Ensembl chr 6:43,980,701...43,990,060
G
LOC103224275
glutathione S-transferase Mu 1
susceptibility disease_progression onset
ISO
DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:12792225 RGD:12792249 RGD:5490267
NCBI chr20:23,854,969...23,861,634
G
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr 3:24,545,641...24,748,992
G
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:43,752,341...43,842,958
Ensembl chr20:43,752,370...43,842,766
G
MAG
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr 6:30,224,873...30,246,277
Ensembl chr 6:30,227,442...30,246,481
G
MBP
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr18:2,844,154...2,996,640
Ensembl chr18:2,868,795...2,997,046
G
MCAM
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr 1:110,682,631...110,691,717
Ensembl chr 1:110,684,458...110,691,707
G
MHC-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) DNA:polymorphism: :HLA-DPB1*0501 (human)
CTD RGD
PMID:17125797 PMID:17956852 PMID:32560041
RGD:150429801 RGD:150429806
NCBI chr17:38,996,329...39,007,097
G
MHC-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:21741664
RGD:5147555
NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
G
MHC-DRA
major histocompatibility complex, class II, DR alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:polymorphism:promoter (human) DNA:SNPs: :multiple (human)
CTD RGD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chr17:39,623,324...39,628,464
Ensembl chr17:39,622,402...39,629,261
G
MMP12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr 1:94,243,061...94,261,035
Ensembl chr 1:94,243,875...94,259,591
G
MMP9
matrix metallopeptidase 9
no_association susceptibility
ISO
DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell DNA:SNP:promoter:-1562C>T (human) DNA:SNP, repeat:promoter:-1562C>T (human)
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MOG
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr17:42,947,174...42,963,046
Ensembl chr17:42,947,279...42,962,159
G
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr11:118,496,485...118,576,904
Ensembl chr11:118,495,466...118,574,162
G
NABP1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:77,210,624...77,222,340
Ensembl chr10:77,210,702...77,218,289
G
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr20:2,767,864...2,780,336
Ensembl chr20:2,768,064...2,780,704
G
NECTIN2
nectin cell adhesion molecule 2
severity no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chr 6:38,320,791...38,361,419
Ensembl chr 6:38,320,933...38,361,742
G
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:60,759,411...60,959,558
Ensembl chr17:60,911,264...60,959,603
G
NEFH
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr19:12,357,982...12,375,449
G
NEFL
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chr 8:23,077,085...23,083,213
Ensembl chr 8:23,077,086...23,083,222
G
NGFR
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr16:69,894,000...69,914,209
Ensembl chr16:69,894,139...69,912,189
G
NLRP3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr25:84,431,436...84,463,387
Ensembl chr25:84,434,527...84,463,249
G
NONO
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:61,082,923...61,110,895
G
NOTCH4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr17:39,806,864...39,837,101
Ensembl chr17:39,808,035...39,837,365
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr 1:18,041,495...18,061,196
Ensembl chr 1:18,041,830...18,051,501
G
P2RX7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr11:116,505,975...116,560,151
Ensembl chr11:116,529,346...116,563,059
G
PDCD1
programmed cell death 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chr10:127,877,383...127,886,234
Ensembl chr10:127,878,554...127,886,088
G
PHACTR2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr13:29,401,562...29,702,719
Ensembl chr13:29,401,382...29,560,452
G
PLA2G7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr17:25,538,645...25,571,230
Ensembl chr17:25,538,438...25,574,269
G
PNMT
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr16:66,496,290...66,498,840
Ensembl chr16:66,496,027...66,499,111
G
POLG
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr14:82,491,296...82,499,289
Ensembl chr14:82,494,323...82,499,447
G
PRF1
perforin 1
ISO
DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 protein:increased expression:blood, T cell
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chr 9:60,692,544...60,698,000
Ensembl chr 9:60,692,600...60,698,465
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr13:88,856,056...90,329,379
G
PRNP
prion protein (Kanno blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:33,368,020...33,384,556
Ensembl chr 2:33,369,629...33,370,366
G
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr17:39,246,356...39,251,852
Ensembl chr17:39,245,854...39,251,842
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr20:19,792,807...19,855,784
Ensembl chr20:19,793,083...19,855,827
G
PTPRC
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr25:30,655,014...30,777,367
Ensembl chr25:30,653,044...30,777,303
G
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr27:23,911,084...24,023,856
G
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr29:11,592,929...11,638,955
Ensembl chr29:11,592,604...11,638,860
G
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr22:10,757,381...10,809,257
Ensembl chr22:10,757,337...10,772,704
G
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 8:95,107,679...95,161,592
Ensembl chr 8:95,105,016...95,139,012
G
RNF217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr13:48,612,687...48,743,821
G
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr25:59,305,610...59,333,789
Ensembl chr25:59,322,913...59,330,668
G
SH2D2A
SH2 domain containing 2A
susceptibility
ISO
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chr20:7,052,170...7,063,262
Ensembl chr20:7,052,797...7,062,324
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr21:123,929,937...123,942,451
Ensembl chr21:123,932,900...123,942,395
G
SLC11A1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chr10:104,276,553...104,288,466
G
SPP1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
G
STAT4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr10:76,553,626...76,708,540
Ensembl chr10:76,553,606...76,674,928
G
SYS1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:18,471,183...18,475,941
Ensembl chr 2:18,472,155...18,475,801
G
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs:CDs:p.V379I, A565T(human) DNA:synonymous mutation: :
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chr17:39,266,870...39,277,658
G
TLR4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
TNF
tumor necrosis factor
disease_progression no_association
ISO
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
G
TNFAIP3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr13:35,537,103...35,553,396
Ensembl chr13:35,537,102...35,549,197
G
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
G
TNFSF14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 6:6,235,641...6,241,706
Ensembl chr 6:6,236,193...6,241,311
G
TNFSF9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr 6:6,131,157...6,136,345
Ensembl chr 6:6,131,571...6,135,463
G
TRAF1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr12:18,647,131...18,672,685
Ensembl chr12:18,650,190...18,670,643
G
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr 6:9,399,945...9,420,054
Ensembl chr 6:9,399,775...9,417,630
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr20:32,616,425...32,635,903
Ensembl chr20:32,615,333...32,635,862
G
VDR
vitamin D receptor
susceptibility no_association
ISO
DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human)
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chr11:44,062,198...44,126,295
Ensembl chr11:44,065,457...44,166,684
G
VHL
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr22:46,184,621...46,203,065
Ensembl chr22:46,184,756...46,204,428
G
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr19:11,670,605...11,677,168
G
ZNF267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 5:28,517,588...28,561,125
Ensembl chr 5:28,517,720...28,561,117
G
AQP4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr18:53,729,143...53,742,916
Ensembl chr18:53,729,186...53,743,156
G
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr 9:60,538,718...60,625,903
Ensembl chr 9:60,540,303...60,625,570
G
BCHE
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
G
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr12:74,038,844...74,060,662
Ensembl chr12:74,041,767...74,056,806
G
GC
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
G
GRN
granulin precursor
susceptibility
ISO
DNA:SNPs: :rs2879096, rs4792938(human) protein:increased expression:cerebrospinal fluids
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chr16:62,037,344...62,045,765
Ensembl chr16:62,036,412...62,045,614
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
G
IGFBP3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr21:12,905,309...12,914,199
Ensembl chr21:12,905,280...12,914,205
G
IL4R
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
POLG
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr21:123,929,937...123,942,451
Ensembl chr21:123,932,900...123,942,395
G
ACKR3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr10:122,558,998...122,573,747
Ensembl chr10:122,571,853...122,572,941
G
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr 9:60,538,718...60,625,903
Ensembl chr 9:60,540,303...60,625,570
G
APOA4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr 1:108,186,627...108,190,508
Ensembl chr 1:108,186,921...108,189,698
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
CD36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr21:68,214,875...68,309,336
Ensembl chr21:68,216,201...68,268,669
G
CD80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr22:61,258,281...61,294,772
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr26:7,735,972...7,761,355
Ensembl chr26:7,694,014...7,761,342
G
CTSS
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
G
GRN
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr16:62,037,344...62,045,765
Ensembl chr16:62,036,412...62,045,614
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
G
KLC1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr24:81,617,049...81,632,845
G
MMP19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr11:51,786,076...51,794,325
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
NEFH
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr19:12,357,982...12,375,449
G
NEFL
neurofilament light chain
ISO
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chr 8:23,077,085...23,083,213
Ensembl chr 8:23,077,086...23,083,222
G
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
G
NOG
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr16:36,816,783...36,818,693
Ensembl chr16:36,817,476...36,818,174
G
S100B
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
G
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
G
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all